✦ LIBER ✦

Lack of transmission of neutrophil and platelet antibodies by intravenous immunoglobulin in bone marrow transplant patients

✍ Scribed by T.R. KLUMPP; J.H. HERMAN; K.F. MANGAN; M.K. SCHNELL; S.L. GOLDBERG; J.S. MACWNALD

Book ID: 114439863
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 229 KB
Volume: 34
Category: Article
ISSN: 0372-1248
DOI: 10.1046/j.1537-2995.1994.34894353462.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of intravenous immunogl

Pharmacokinetics of intravenous immunoglobulin (GAMMAGARDR) in bone marrow transplant patients

✍ Kenneth H. Rand; Katherine Gibbs; Hartmut Derendorf; John Graham-Pole 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Effect of IgM-enriched intravenous immun

Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation

✍ S. K. JACKSON; J. PARTON; R. A. BARNES; C. H. POYNTON; C. FEGAN 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Low incidence of red cell and HLA antibo

Low incidence of red cell and HLA antibody formation by bone marrow transplant patients

✍ A.A. Abou-Elella; T.A. Camarillo; M.B. Allen; S. Barclay; J.A. Pierce; H.K. Holl 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 425 KB

Evaluating pharmacokinetics and pharmaco

Evaluating pharmacokinetics and pharmacodynamics of intravenous busulfan in pediatric patients receiving bone marrow transplantation

✍ Amy H. Kim; John C. Tse; Alan Ikeda; Theodore B. Moore 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Treatment of disseminated cancer by intr

Treatment of disseminated cancer by intravenous hydroxyurea and autogenous bone-marrow transplants: Experience with 35 patients

✍ Dr. Irving M. Ariel 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

## Abstract Massive doses of hydroxyurea (Hydrea) were given to 35 patients suffering from different cancers. Protection to the hematopoietic system was obtained by autogenous marrow transfusions. The clinical response obtained was not considered superior to the results obtained by administering t

233: Evaluating Pharmacokinetics and Pha

233: Evaluating Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Pediatric Patients Receiving Bone Marrow Transplantation

✍ A. Kim; J. Tse; T.B. Moore 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB